Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tomography, X-Ray Computed | 23 | 2021 | 1520 | 1.760 |
Why?
|
Thrombin | 6 | 2003 | 21 | 0.850 |
Why?
|
Ultrasonography, Doppler | 3 | 2010 | 24 | 0.670 |
Why?
|
Postoperative Complications | 6 | 2017 | 1208 | 0.670 |
Why?
|
Aneurysm, False | 6 | 2003 | 46 | 0.670 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 2 | 2013 | 8 | 0.630 |
Why?
|
Hemostatics | 4 | 2003 | 26 | 0.610 |
Why?
|
Portal Vein | 4 | 2010 | 38 | 0.600 |
Why?
|
Coronary Artery Disease | 2 | 2014 | 275 | 0.580 |
Why?
|
Adenocarcinoma | 5 | 2008 | 323 | 0.560 |
Why?
|
Middle Aged | 42 | 2018 | 16383 | 0.530 |
Why?
|
Contrast Media | 9 | 2015 | 406 | 0.530 |
Why?
|
Catheter Ablation | 4 | 2012 | 146 | 0.520 |
Why?
|
Catheterization | 5 | 2007 | 111 | 0.510 |
Why?
|
Thrombophlebitis | 4 | 1999 | 14 | 0.430 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 69 | 0.430 |
Why?
|
Software | 3 | 2014 | 366 | 0.430 |
Why?
|
Hypertension, Portal | 1 | 2013 | 14 | 0.430 |
Why?
|
Calcinosis | 1 | 2014 | 81 | 0.420 |
Why?
|
Male | 44 | 2018 | 27846 | 0.420 |
Why?
|
Coronary Angiography | 1 | 2014 | 178 | 0.420 |
Why?
|
Surgery, Computer-Assisted | 1 | 2013 | 55 | 0.410 |
Why?
|
Femoral Artery | 3 | 2003 | 103 | 0.410 |
Why?
|
Aged, 80 and over | 19 | 2018 | 5138 | 0.400 |
Why?
|
Pancreas | 2 | 2014 | 146 | 0.390 |
Why?
|
Mesenteric Lymphadenitis | 1 | 2012 | 2 | 0.390 |
Why?
|
Aged | 26 | 2018 | 13458 | 0.380 |
Why?
|
Liver Neoplasms | 2 | 2012 | 276 | 0.380 |
Why?
|
Liver Transplantation | 2 | 2012 | 207 | 0.380 |
Why?
|
Female | 41 | 2018 | 30836 | 0.380 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2012 | 50 | 0.370 |
Why?
|
Diagnostic Imaging | 2 | 2013 | 245 | 0.370 |
Why?
|
Intestine, Small | 2 | 2005 | 78 | 0.370 |
Why?
|
Algorithms | 3 | 2014 | 980 | 0.360 |
Why?
|
Humans | 58 | 2021 | 59565 | 0.350 |
Why?
|
Catheters, Indwelling | 3 | 2007 | 67 | 0.350 |
Why?
|
Mesenteric Vascular Occlusion | 2 | 2000 | 14 | 0.340 |
Why?
|
Adult | 25 | 2018 | 15732 | 0.330 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2012 | 167 | 0.330 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2012 | 300 | 0.330 |
Why?
|
Femoral Vein | 2 | 2007 | 18 | 0.330 |
Why?
|
Graft Occlusion, Vascular | 3 | 2006 | 62 | 0.320 |
Why?
|
Pancreatic Neoplasms | 4 | 2004 | 331 | 0.310 |
Why?
|
Iopamidol | 3 | 2012 | 13 | 0.300 |
Why?
|
Catheterization, Central Venous | 3 | 2006 | 85 | 0.290 |
Why?
|
Sigmoid Neoplasms | 1 | 2008 | 2 | 0.290 |
Why?
|
Sigmoid Diseases | 1 | 2008 | 5 | 0.290 |
Why?
|
Sensitivity and Specificity | 8 | 2014 | 1099 | 0.290 |
Why?
|
Diverticulitis, Colonic | 1 | 2008 | 32 | 0.290 |
Why?
|
Aorta, Abdominal | 2 | 1998 | 58 | 0.280 |
Why?
|
Terminology as Topic | 2 | 2000 | 133 | 0.270 |
Why?
|
Common Bile Duct | 2 | 2004 | 19 | 0.270 |
Why?
|
Carotid Arteries | 1 | 2007 | 62 | 0.270 |
Why?
|
Iatrogenic Disease | 3 | 2003 | 59 | 0.270 |
Why?
|
Carotid Artery Diseases | 1 | 2007 | 63 | 0.260 |
Why?
|
Fibrin | 1 | 2006 | 18 | 0.260 |
Why?
|
Incidental Findings | 3 | 2018 | 41 | 0.260 |
Why?
|
Impotence, Vasculogenic | 1 | 2005 | 1 | 0.250 |
Why?
|
Penile Erection | 1 | 2005 | 4 | 0.250 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2008 | 652 | 0.250 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2005 | 27 | 0.250 |
Why?
|
Image-Guided Biopsy | 2 | 2017 | 36 | 0.250 |
Why?
|
Penis | 1 | 2005 | 22 | 0.250 |
Why?
|
Stents | 3 | 2010 | 465 | 0.250 |
Why?
|
Piperazines | 1 | 2005 | 74 | 0.240 |
Why?
|
Retrospective Studies | 11 | 2021 | 6113 | 0.230 |
Why?
|
Cystic Duct | 1 | 2004 | 5 | 0.230 |
Why?
|
Renal Dialysis | 1 | 2006 | 189 | 0.230 |
Why?
|
Biopsy | 2 | 2014 | 410 | 0.230 |
Why?
|
Cholecystitis | 1 | 2004 | 27 | 0.230 |
Why?
|
Thrombosis | 2 | 2000 | 187 | 0.230 |
Why?
|
Cholestasis | 1 | 2004 | 54 | 0.220 |
Why?
|
Tomography, Spiral Computed | 1 | 2003 | 21 | 0.210 |
Why?
|
Tissue Plasminogen Activator | 2 | 2006 | 125 | 0.210 |
Why?
|
Ultrasonography | 6 | 2010 | 458 | 0.210 |
Why?
|
Colonic Diseases | 1 | 2003 | 34 | 0.210 |
Why?
|
Radiography, Abdominal | 2 | 2017 | 26 | 0.210 |
Why?
|
Radiography, Interventional | 3 | 2017 | 72 | 0.210 |
Why?
|
Hemorheology | 2 | 2000 | 6 | 0.210 |
Why?
|
Pulse | 2 | 2002 | 15 | 0.210 |
Why?
|
Ultrasonography, Interventional | 1 | 2003 | 92 | 0.200 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2003 | 77 | 0.200 |
Why?
|
Ultrasonic Therapy | 1 | 2002 | 8 | 0.200 |
Why?
|
Bronchial Arteries | 1 | 2002 | 3 | 0.200 |
Why?
|
Hemoptysis | 1 | 2002 | 8 | 0.200 |
Why?
|
Feasibility Studies | 4 | 2008 | 528 | 0.190 |
Why?
|
Gastric Fistula | 1 | 2002 | 4 | 0.190 |
Why?
|
Cutaneous Fistula | 1 | 2002 | 7 | 0.190 |
Why?
|
Lung Neoplasms | 2 | 2021 | 586 | 0.190 |
Why?
|
Cardiac Catheterization | 2 | 2001 | 254 | 0.190 |
Why?
|
Prospective Studies | 6 | 2008 | 3076 | 0.190 |
Why?
|
Device Removal | 1 | 2002 | 64 | 0.180 |
Why?
|
Venous Thrombosis | 1 | 2002 | 111 | 0.180 |
Why?
|
Fistula | 1 | 2001 | 13 | 0.180 |
Why?
|
Pancreatic Fistula | 1 | 2001 | 18 | 0.180 |
Why?
|
Splanchnic Circulation | 2 | 2000 | 16 | 0.180 |
Why?
|
Pancreaticoduodenectomy | 1 | 2001 | 63 | 0.180 |
Why?
|
Radiosurgery | 1 | 2021 | 61 | 0.170 |
Why?
|
Liver Circulation | 1 | 2000 | 11 | 0.170 |
Why?
|
Brachial Artery | 2 | 1999 | 28 | 0.170 |
Why?
|
Radiography | 3 | 2012 | 518 | 0.170 |
Why?
|
Skin Diseases | 1 | 2001 | 76 | 0.170 |
Why?
|
Plasminogen Activators | 1 | 2000 | 10 | 0.170 |
Why?
|
Injections, Intravenous | 4 | 2005 | 155 | 0.160 |
Why?
|
Pulmonary Embolism | 2 | 1999 | 169 | 0.160 |
Why?
|
Fiducial Markers | 2 | 2021 | 4 | 0.160 |
Why?
|
Embolization, Therapeutic | 1 | 2002 | 310 | 0.150 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 1998 | 46 | 0.150 |
Why?
|
Abdominal Neoplasms | 1 | 1998 | 17 | 0.150 |
Why?
|
Thoracic Neoplasms | 1 | 1998 | 12 | 0.150 |
Why?
|
Splenic Neoplasms | 1 | 2018 | 8 | 0.150 |
Why?
|
Thrombectomy | 1 | 2000 | 213 | 0.140 |
Why?
|
Ultrasonography, Doppler, Duplex | 4 | 2015 | 49 | 0.140 |
Why?
|
Ultrasonography, Doppler, Color | 4 | 2001 | 25 | 0.140 |
Why?
|
Renal Artery | 1 | 1996 | 31 | 0.130 |
Why?
|
Diagnosis, Differential | 2 | 2010 | 939 | 0.130 |
Why?
|
Drainage | 1 | 2017 | 150 | 0.130 |
Why?
|
Diverticulum, Colon | 1 | 1995 | 4 | 0.130 |
Why?
|
Phlebography | 3 | 2010 | 43 | 0.120 |
Why?
|
Bacterial Infections | 1 | 2017 | 140 | 0.120 |
Why?
|
Liposarcoma | 1 | 2015 | 8 | 0.120 |
Why?
|
Ambulatory Care | 1 | 2017 | 305 | 0.120 |
Why?
|
Vascular Neoplasms | 1 | 2015 | 16 | 0.120 |
Why?
|
Vena Cava, Inferior | 1 | 2015 | 28 | 0.120 |
Why?
|
Models, Theoretical | 2 | 2008 | 256 | 0.110 |
Why?
|
Regional Blood Flow | 2 | 2008 | 108 | 0.110 |
Why?
|
Aortography | 3 | 2008 | 56 | 0.110 |
Why?
|
Software Validation | 1 | 2014 | 8 | 0.110 |
Why?
|
Statistics, Nonparametric | 2 | 2005 | 209 | 0.110 |
Why?
|
Forearm | 1 | 1994 | 19 | 0.110 |
Why?
|
Vascular Diseases | 2 | 1995 | 75 | 0.110 |
Why?
|
Radiographic Image Enhancement | 1 | 2014 | 98 | 0.110 |
Why?
|
Hand | 1 | 1994 | 69 | 0.110 |
Why?
|
Pneumothorax | 1 | 2014 | 49 | 0.110 |
Why?
|
Swine | 3 | 2003 | 355 | 0.110 |
Why?
|
Partial Thromboplastin Time | 1 | 1993 | 9 | 0.100 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 1993 | 10 | 0.100 |
Why?
|
Treatment Outcome | 6 | 2017 | 5310 | 0.100 |
Why?
|
Graft vs Host Disease | 1 | 2014 | 105 | 0.100 |
Why?
|
Pain | 1 | 1995 | 397 | 0.100 |
Why?
|
Mucocele | 1 | 2012 | 2 | 0.100 |
Why?
|
Esophageal Diseases | 1 | 2012 | 16 | 0.100 |
Why?
|
Respiration Disorders | 1 | 2012 | 23 | 0.100 |
Why?
|
Heparin | 1 | 1993 | 111 | 0.100 |
Why?
|
Treatment Failure | 2 | 2003 | 186 | 0.100 |
Why?
|
Hemorrhage | 2 | 1993 | 259 | 0.100 |
Why?
|
Hepatic Artery | 1 | 2012 | 20 | 0.090 |
Why?
|
Constriction, Pathologic | 2 | 2010 | 113 | 0.090 |
Why?
|
Thrombolytic Therapy | 1 | 1993 | 184 | 0.090 |
Why?
|
Hot Temperature | 1 | 2012 | 126 | 0.090 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2014 | 328 | 0.090 |
Why?
|
Lymph Nodes | 1 | 2012 | 215 | 0.090 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 737 | 0.090 |
Why?
|
Polyps | 1 | 2010 | 4 | 0.090 |
Why?
|
Reproducibility of Results | 2 | 2014 | 1565 | 0.090 |
Why?
|
Gallbladder Diseases | 1 | 2010 | 25 | 0.090 |
Why?
|
Acute Disease | 2 | 2004 | 660 | 0.090 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2010 | 41 | 0.090 |
Why?
|
Hospitalization | 1 | 2017 | 1296 | 0.080 |
Why?
|
Hepatectomy | 1 | 2010 | 61 | 0.080 |
Why?
|
Emergency Service, Hospital | 1 | 2017 | 1024 | 0.080 |
Why?
|
Equipment Failure | 2 | 2007 | 63 | 0.080 |
Why?
|
Blood Volume | 2 | 2008 | 42 | 0.080 |
Why?
|
Vascular Patency | 3 | 2006 | 138 | 0.080 |
Why?
|
Case-Control Studies | 2 | 2010 | 1058 | 0.080 |
Why?
|
Liver Diseases | 1 | 2010 | 137 | 0.080 |
Why?
|
Angiography | 4 | 2015 | 145 | 0.080 |
Why?
|
Bibliometrics | 1 | 2008 | 27 | 0.070 |
Why?
|
Young Adult | 2 | 2018 | 4285 | 0.070 |
Why?
|
Cineradiography | 1 | 2008 | 1 | 0.070 |
Why?
|
Diatrizoate Meglumine | 1 | 2008 | 6 | 0.070 |
Why?
|
Gastrointestinal Transit | 1 | 2008 | 6 | 0.070 |
Why?
|
Intestinal Absorption | 1 | 2008 | 29 | 0.070 |
Why?
|
Risk Factors | 3 | 2012 | 5005 | 0.070 |
Why?
|
Injections | 2 | 2005 | 76 | 0.070 |
Why?
|
Blood Flow Velocity | 2 | 2005 | 68 | 0.070 |
Why?
|
Atherectomy | 2 | 1997 | 12 | 0.070 |
Why?
|
Kinetics | 1 | 2008 | 751 | 0.070 |
Why?
|
Elective Surgical Procedures | 1 | 2007 | 114 | 0.070 |
Why?
|
Preoperative Care | 1 | 2007 | 180 | 0.060 |
Why?
|
Papaverine | 1 | 2005 | 6 | 0.060 |
Why?
|
Alprostadil | 1 | 2005 | 6 | 0.060 |
Why?
|
Phentolamine | 1 | 2005 | 8 | 0.060 |
Why?
|
Triiodobenzoic Acids | 1 | 2005 | 11 | 0.060 |
Why?
|
Sildenafil Citrate | 1 | 2005 | 11 | 0.060 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2005 | 15 | 0.060 |
Why?
|
Sulfones | 1 | 2005 | 36 | 0.060 |
Why?
|
Periodicals as Topic | 1 | 2008 | 166 | 0.060 |
Why?
|
Purines | 1 | 2005 | 38 | 0.060 |
Why?
|
Coronary Artery Bypass | 1 | 2007 | 280 | 0.060 |
Why?
|
Patient Selection | 1 | 2007 | 466 | 0.060 |
Why?
|
Administration, Oral | 1 | 2005 | 354 | 0.060 |
Why?
|
Radiology | 1 | 2008 | 238 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2018 | 2346 | 0.060 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2003 | 16 | 0.050 |
Why?
|
Logistic Models | 1 | 2007 | 1239 | 0.050 |
Why?
|
Vena Cava Filters | 1 | 2003 | 23 | 0.050 |
Why?
|
Embolism | 1 | 2003 | 39 | 0.050 |
Why?
|
Mesenteric Veins | 2 | 2000 | 11 | 0.050 |
Why?
|
Injections, Intra-Arterial | 1 | 2002 | 20 | 0.050 |
Why?
|
Image Enhancement | 1 | 2003 | 188 | 0.050 |
Why?
|
Intubation, Gastrointestinal | 1 | 2002 | 21 | 0.050 |
Why?
|
Mammary Arteries | 1 | 2001 | 10 | 0.050 |
Why?
|
Gastrostomy | 1 | 2002 | 29 | 0.050 |
Why?
|
Models, Animal | 1 | 2002 | 222 | 0.050 |
Why?
|
Mass Screening | 1 | 2007 | 649 | 0.050 |
Why?
|
Recurrence | 2 | 2001 | 605 | 0.050 |
Why?
|
Pancreaticojejunostomy | 1 | 2001 | 5 | 0.050 |
Why?
|
Injections, Intralesional | 1 | 2001 | 12 | 0.050 |
Why?
|
Equipment Design | 1 | 2002 | 331 | 0.050 |
Why?
|
Computer Simulation | 1 | 2003 | 459 | 0.040 |
Why?
|
Anastomosis, Surgical | 1 | 2001 | 108 | 0.040 |
Why?
|
Mesenteric Artery, Superior | 1 | 2000 | 14 | 0.040 |
Why?
|
Heart | 1 | 2002 | 275 | 0.040 |
Why?
|
Intermittent Claudication | 2 | 1997 | 53 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 1997 | 248 | 0.040 |
Why?
|
Leg | 2 | 1996 | 86 | 0.040 |
Why?
|
Common Bile Duct Diseases | 1 | 1998 | 10 | 0.040 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2000 | 107 | 0.040 |
Why?
|
Pancreatic Diseases | 1 | 1998 | 38 | 0.040 |
Why?
|
Pancreatic Ducts | 1 | 1998 | 30 | 0.040 |
Why?
|
False Negative Reactions | 1 | 1998 | 40 | 0.040 |
Why?
|
Urography | 1 | 1998 | 12 | 0.040 |
Why?
|
Ureter | 1 | 1998 | 24 | 0.040 |
Why?
|
Costs and Cost Analysis | 2 | 1995 | 98 | 0.030 |
Why?
|
Saphenous Vein | 1 | 1997 | 51 | 0.030 |
Why?
|
Adolescent | 2 | 1999 | 5862 | 0.030 |
Why?
|
Spleen | 1 | 2018 | 480 | 0.030 |
Why?
|
Animals | 3 | 2003 | 19686 | 0.030 |
Why?
|
Iliac Artery | 1 | 1996 | 49 | 0.030 |
Why?
|
Veins | 1 | 1996 | 61 | 0.030 |
Why?
|
Kidney | 1 | 1998 | 414 | 0.030 |
Why?
|
Arterial Occlusive Diseases | 1 | 1996 | 72 | 0.030 |
Why?
|
Aortic Diseases | 1 | 1996 | 72 | 0.030 |
Why?
|
Thromboembolism | 1 | 1996 | 70 | 0.030 |
Why?
|
Causality | 1 | 1995 | 57 | 0.030 |
Why?
|
Radiology, Interventional | 1 | 1995 | 28 | 0.030 |
Why?
|
Liver | 1 | 1999 | 796 | 0.030 |
Why?
|
Atrophy | 1 | 2014 | 76 | 0.030 |
Why?
|
Time Factors | 2 | 2003 | 3625 | 0.030 |
Why?
|
Prosthesis Implantation | 1 | 2014 | 32 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 1995 | 203 | 0.030 |
Why?
|
Fibrinogen | 1 | 1993 | 32 | 0.030 |
Why?
|
Respiratory Sounds | 1 | 2012 | 22 | 0.020 |
Why?
|
Hematoma | 1 | 1993 | 68 | 0.020 |
Why?
|
Predictive Value of Tests | 4 | 1997 | 1034 | 0.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 147 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 1992 | 81 | 0.020 |
Why?
|
Aortic Rupture | 1 | 1992 | 54 | 0.020 |
Why?
|
Thoracic Injuries | 1 | 1992 | 46 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 1993 | 452 | 0.020 |
Why?
|
Prevalence | 1 | 1995 | 1258 | 0.020 |
Why?
|
Wounds, Nonpenetrating | 1 | 1992 | 105 | 0.020 |
Why?
|
Chronic Disease | 1 | 2014 | 719 | 0.020 |
Why?
|
Lung | 1 | 1996 | 921 | 0.020 |
Why?
|
Cholecystectomy | 1 | 2010 | 31 | 0.020 |
Why?
|
Gallbladder Neoplasms | 1 | 2010 | 16 | 0.020 |
Why?
|
Pressure | 2 | 2000 | 76 | 0.020 |
Why?
|
Critical Illness | 1 | 2012 | 332 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2008 | 154 | 0.020 |
Why?
|
Biomarkers, Tumor | 1 | 2010 | 461 | 0.020 |
Why?
|
Observer Variation | 2 | 1998 | 205 | 0.020 |
Why?
|
Administration, Cutaneous | 1 | 2001 | 28 | 0.010 |
Why?
|
Retreatment | 1 | 2000 | 46 | 0.010 |
Why?
|
Transducers | 1 | 2000 | 26 | 0.010 |
Why?
|
Angioplasty, Balloon | 1 | 2000 | 58 | 0.010 |
Why?
|
Therapy, Computer-Assisted | 1 | 1999 | 24 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2000 | 167 | 0.010 |
Why?
|
Necrosis | 1 | 1999 | 140 | 0.010 |
Why?
|
Cattle | 1 | 1999 | 304 | 0.010 |
Why?
|
Kidney Calices | 1 | 1998 | 1 | 0.010 |
Why?
|
In Vitro Techniques | 1 | 1999 | 473 | 0.010 |
Why?
|
Ureteral Diseases | 1 | 1998 | 3 | 0.010 |
Why?
|
Supine Position | 1 | 1998 | 31 | 0.010 |
Why?
|
Kidney Pelvis | 1 | 1998 | 10 | 0.010 |
Why?
|
Prone Position | 1 | 1998 | 28 | 0.010 |
Why?
|
Urothelium | 1 | 1998 | 22 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1998 | 103 | 0.010 |
Why?
|
Hematuria | 1 | 1998 | 20 | 0.010 |
Why?
|
Urinary Bladder | 1 | 1998 | 38 | 0.010 |
Why?
|
Abdomen | 1 | 1998 | 91 | 0.010 |
Why?
|
Mesenteric Arteries | 1 | 1997 | 9 | 0.010 |
Why?
|
Kidney Diseases | 1 | 1998 | 170 | 0.010 |
Why?
|
Life Tables | 1 | 1996 | 23 | 0.010 |
Why?
|
Ankle | 1 | 1996 | 24 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1996 | 121 | 0.010 |
Why?
|
Physical Examination | 1 | 1996 | 105 | 0.010 |
Why?
|
Aneurysm | 1 | 1996 | 56 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 1999 | 678 | 0.010 |
Why?
|
Blood Pressure | 1 | 1996 | 497 | 0.010 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 1996 | 241 | 0.010 |
Why?
|
Incidence | 1 | 1996 | 1241 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 1996 | 1189 | 0.010 |
Why?
|
Mediastinal Diseases | 1 | 1992 | 15 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 1995 | 2066 | 0.000 |
Why?
|
Neoplasms | 1 | 1995 | 1235 | 0.000 |
Why?
|